Trial Comparing Cisplatin With or Without Gemcitabine in Patients With Carcinoma of Unknown Primary
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This is a randomized phase III trial comparing cisplatin with or without gemcitabine in
patients with carcinoma of unknown primary and a predicted favorable prognosis.
The purpose of this trial is to compare the overall survival rates of patients with carcinoma
of unknown primary (CUP) and a predicted favorable prognosis according to the French
classification treated with cisplatin with or without gemcitabine.